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Abstract
Objective: Understand the meanings of breastfeeding inhibition to prevent vertical transmission among 
women living with HTLV-1 (WLHTLV).
Methods: A qualitative research with participant observation and in-depth interviews was undertaken, using a 
pretested thematic script, analyzed by means of Bardin’s thematic content analysis. The participants were 13 
people - 11 women and two men - over 18 years of age, diagnosed with HTLV-1 and without co-infections. 
The study was undertaken at a private room in a specialized center in São Paulo between June/2006 and 
April/2008, where the researcher worked, so that she was familiar with and had access to the users. The 
subjects were selected by convenience, during the participant observation. The subjects’ reports were 
recorded, transcribed and analyzed in search of senses and meanings to elaborate the categories. Excerpts 
were presented, identified by fictitious names.
Results: Breastfeeding inhibition is a complex decision that is even more difficult in a context in which the 
health team does not know this infection.
Conclusion: The lack of knowledge on HTLV-1 in the hospital context is a risk for the vertical transmission of 
this virus and entails significant emotional consequences. The health team needs information and education 
for comprehensive care and welcoming of WLHTLV’s specific needs.
Resumo
Objetivo: Compreender os sentidos da inibição da amamentação como prevenção da transmissão vertical 
entre mulheres vivendo com HTLV-1 (MVHTLV).
Métodos: Trata-se de pesquisa qualitativa com observação participante e entrevistas em profundidade, 
por meio de roteiro temático, pela análise de conteúdo temática de Bardin, pré-testado e realizados com 
13 pessoas - 11 mulheres e dois homens - maiores de 18 anos, diagnosticados com HTLV-1 e sem co-
infecções, entre Junho/2006 a Abril/2008, em sala reservada de centro especializado em São Paulo, onde 
atuava a pesquisadora, psicóloga, com familiaridade e acesso aos usuários. A seleção dos sujeitos ocorreu 
por conveniência durante a observação participante. Os relatos dos sujeitos foram gravados, transcritos 
e analisados na busca dos sentidos e significados para elaboração das categorias e, foram apresentados 
trechos destes, identificados por nomes fictícios.
Resultados: A inibição da amamentação é uma decisão complexa dificultada em um contexto de 
desconhecimento dessa infecção pela equipe de saúde.
Conclusão: O desconhecimento do HTLV-1 no contexto hospitalar se torna um risco para a transmissão 
vertical desse vírus, além de consequências emocionais significativas. Indica-se a necessidade de informação 
e formação da equipe de saúde para um cuidado integral e o acolhimento das necessidades específicas de 
MVHTLV.
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Introduction
HTLV-1 causes an infection that is unknown to 
most health professionals and is neglected in public 
health,(1-4) as its true epidemiological dimension is 
only estimated, considering that, between 10 and 
20 million people have been infected around the 
world.(5) It is relevant that most people are asymp-
tomatic (about 95% of the cases), do not know 
their serological status and can infect their partner 
or children.(3-7)
Zihlmann et al.(3) appoint the invisibility of 
HTLV in Brazil and around the world, raising a 
discussion about the influence of the hegemon-
ic healthcare model that considers the low risk of 
illness as a justification for neglecting this endem-
ic condition. Thus, the lack of knowledge about 
HTLV-1 entails implications for care practice, pre-
vents the identification of infected patients and per-
petuates the infection in society.
The infection by HTLV-1 is mixed up with the 
infection by HIV, but each entails different illnesses 
and demands distinct treatments, as the infection by 
HTLV-1 does not respond to antiretroviral drugs. 
The reasons why few people evolve to diseases associ-
ated with HTLV-1 are yet unknown, the most com-
mon of which are adult T-cell leukemia/lymphoma 
(LTTA) and HTLV-1-associated myelopathy/tropi-
cal spastic paraparesis (HAM/TSP).(7)
The infections by HIV and HTLV-1 have iden-
tical transmission forms,(7) but epidemiological data 
appoint that the main transmission form of HTLV-
1 is through breastfeeding. Therefore, the main 
form to prevent the vertical transmission of HTLV-
1 is the interruption of breastfeeding.(8,9)
In Brazil, few epidemiological studies exist on 
the endemic condition of HTLV-1. The great het-
erogeneity of prevalence rates in the serological 
screening of blood bank donors in large Brazilian 
urban areas is known, the highest prevalence be-
ing found in the cities of São Luiz do Maranhão 
(10/1,000 donors), Salvador (9.4/1,000 donors), 
followed by Belém (9.1/1,000 donors).(6)
Until recently, Japan presented high vertical 
transmission rates of HTLV-1 but, through pub-
lic policy actions that established prenatal serum 
screening among pregnant women and the inter-
ruption of breastfeeding for seropositive patients, 
the vertical transmission rate dropped from 20% to 
approximately 3%.(10)
In Brazil, few studies exist on the prevalence of 
HTLV-1 among pregnant women. In a study de-
veloped in Salvador, a rate of 0.88 % of the preg-
nant women from the low socioeconomic level was 
indicated.(11)  Between 2002 and 2006, a study was 
developed in Campo Grande, revealing a preva-
lence rate of 0.13% of HTLV 1/2 among pregnant 
women.(12)
The duration of the breastfeeding interferes in 
the vertical transmission risk. If breastfeeding can-
not be avoided for socioeconomic reasons, however, 
a maximum of six months is recommended.(13,14) 
The most accepted recommendation - including in 
Brazil - is the interruption of breastfeeding to pre-
vent the vertical transmission.(7)
One of the few disclosure actions on HTLV-1 
in Brazil took place in 2003: the Recommendation 
Guide on the Management of HTLV.(7) Preventive 
actions to cope with HIV/Aids,(15) such as prena-
tal testing or access to formula milk, do not attend 
to specific demands of people living with HTLV 
(PLHTLV), and are rarely extended to women liv-
ing with HTLV (WLHTLV).
Concerning HTLV-1, the identification of in-
fected persons in the family network is a crucial 
problem and, in these cases, secondary actions to 
prevent the risk of vertical transmission of the virus 
need to be considered (especially during breastfeed-
ing). These issues are challenges the public policies 
should face with caution, as reported in Zihlmann.
(16) Therefore, to cope with the vertical transmission 
prevention of this virus (through the interruption 
of breastfeeding), we need to reflect on the place of 
breastfeeding in our society and the possible effects 
of interrupting breastfeeding for the stakeholders.
As from the 19th century, breastfeeding started 
to be considered as a shared social good, or as an 
attribute that characterizes motherhood and wom-
en’s identity, within an essential conception of im-
portance in the health area. Nowadays, the relation 
breastfeeding/weaning can take the form of a clash 
between health and illness, representing a task that 
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needs to be undertaken with pleasure and abne-
gation, as the health professional’s success. In that 
context, the health actions are intended to inform 
the women about the advantages of breastfeeding, 
making them responsible for the future outcomes, 
in a top-down and authoritative care model. That 
logic intends to modulate women’s behavior in fa-
vor of breastfeeding, blaming them for weaning as a 
form of health problem for their children.
Nursing professionals are currently the main 
boosters of this process, exercising power established 
in the health spheres and contributing to dissemi-
nate knowledge that has been validated as scientific. 
Overall, however, these orientations are limited to 
physiological aspects and ignore the women’s social 
and psychological universe. In the past decade, the 
traditional biological reductionism has been pro-
gressively replaced by a new focus on the woman 
as a subject, beyond the idealization surrounding 
breastfeeding in the social imaginary.(17) 
In view of the lack of studies that investigate the 
emotional aspects and meanings of the inhibition 
of breastfeeding in WLHTLV, we can draw paral-
lels with the reports of women living with HIV/
Aids who also inhibited breastfeeding. In addi-
tion, it should be kept in mind that experiencing 
a pregnancy in this context is a complex emotional 
experience loaded with biased feelings. Therefore, 
healthcare needs to be based on the humanization 
perspective, beyond a mere prophylactic practice.(18)
Some studies appoint that, for women liv-
ing with HIV/Aids, being pregnant is equivalent 
to “being healthy”. When the infant is born, the 
impossibility to breastfeed turns into a first “symp-
tom” of HIV in the eyes of society.(19) For Moreno 
et al.,(20) the inhibition to breastfeed among wom-
en living with HIV/Aids is considered something 
punishing and painful (especially the bandaging of 
the breasts). In that sense, the women revealed that 
they did not consider themselves complete and val-
ued as mothers and that, although this action served 
to protect their infant’s health, they felt guilty and 
afraid of being socially judged.
For the pregnant women living with HIV/Aids, 
the mother’s milk gains a new meaning and breast-
feeding turns into a threatening act for their child’s 
integrity.(21) Therefore, in the context of HIV/Aids 
infection, the inhibition of breastfeeding requires 
a symbolic redefinition that makes it difficult to 
exercise the maternal role and articulates a loss ex-
perienced in a melancholic and blameful manner, 
which the woman elaborates little by little, based on 
strategies intended to avoid anguish.(22)
What would the WLHTLV’s experience be like 
concerning the orientation not to breastfeed?
Therefore, the objective in this article is to un-
derstand the meanings of inhibiting breastfeeding 
as a way to prevent the vertical transmission among 
women living with HTLV-1 and, in addition, to 
present related situations on experiences of actually 
interrupting breastfeeding.
Methods
The study is part of a research entitled “From the 
invisibility to the visibility of the subject living with 
the HTLV-1 infection/disease and the place of the 
reproductive decisions in the webs of knowledge 
and care”.(16) In this qualitative study,(23) participant 
observation and in-depth interviews, by means of a 
pretested thematic script,(24) using Bardin’s thematic 
content analysis,(25) were applied to 13 people - 11 
women and two men - over 18 years of age, diag-
nosed with HTLV-1 and without co-infections, be-
tween June/2006 and April/2008, at a private room 
in a specialized center in São Paulo, where the re-
searcher, a psychologist, worked, so that she was fa-
miliar with and had access to the users. The subjects 
were selected by convenience during the participant 
observation.(24) The subjects’ reports were recorded, 
transcribed and analyzed in search of senses and 
meanings for the elaboration of the categories. Ex-
cerpts were presented, identified by means of ficti-
tious names.
Two thematic analysis categories were construct-
ed:(25) The diagnosis of HTLV and the emotional 
implications of the need to inhibit breastfeeding 
and situations experienced at the maternity hospital 
in the postpartum period: the drama of inhibiting 
breastfeeding as the first symptom of an infection 
unknown to the health team.
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Approval for the study was obtained from 
COEP/FSP under 297/06 and COEP/Instituto 
de Infectologia Emílio Ribas 34/06. After receiving 
orientations, the interviewees signed an Informed 
Consent Form, in compliance with resolution 
466/12.
Results and Discussion
The diagnosis of HTLV and the emotional 
implications of the need to inhibit breast-
feeding
Not breastfeeding was like a bomb. We get that expec-
tation, right? I think I won’t have that contact with 
the child, right? Because you’re the only one who can 
breastfeed. That news that I won’t be allowed to breast-
feed really touched me and my husband. He thought 
it would negatively affect the baby. But I think she 
(daughter) won’t miss something she never had! (Ma-
ria, 27 years, married, asymptomatic).
It was sad not to be allowed to breastfeed but, on 
the other hand, I felt relieved to know that was part of 
the care for my daughter not to have the HTLV (Ana, 
27 years, married, symptomatic).
In these women’s statements, we can observe an 
emotional discourse, loaded with expectations on 
motherhood and breastfeeding. These overwhelm-
ing statements indicate that the act of breastfeeding 
would provide an irreplaceable and special bond, 
besides being an act they consider intrinsic in the 
maternal role. That means that WLHTLV anchor 
their female and maternal identity in the breast-
feeding process, in accordance with an idealized and 
socially shared discourse.
They also reveal a clash between emotion and 
reason. If, on the one hand, idealizations continue 
to exist on the act of breastfeeding, on the other, 
the experts’ information on the vertical transmis-
sion risk serve as a reference framework for decision 
making that is intended to guarantee the infant’s 
health. In that sense, the inhibition of breastfeeding 
is a decision that grants them the feeling that they 
regain control over the situation.(14) We can recog-
nize that these women try to accomplish a ratio-
nalization process that may, or may not, facilitate 
an elaboration process. The statements illustrate 
that this is not a response to a simple orientation 
by the health team, but also a position that requires 
involvement from the women, as well as support 
from their family network.
Situations experienced in the postpartum 
period at the maternity hospital: the dra-
ma of inhibiting breastfeeding as the first 
symptom of an infection unknown to the 
health team
Different difficulties were reported in relation to the 
postpartum situation. The health team’s attitude is 
highlighted which, when discovering what the 
HTLV-1 infection is, welcoming the woman and 
family’s singular needs. In Maria’s report, the ap-
propriate welcoming at the maternity hospital and 
the preparation of the health team are observed.(16) 
Her statement illustrates the relief for having been 
allocated to a separate room as, for her and her 
husband, besides having to cope with the need to 
inhibit the breastfeeding, the most difficult was to 
cope with the questioning look of other people and 
give explanations. She felt relieved for not having to 
watch other women breastfeed.
I stayed at a separate room. Nobody came in ask-
ing. It would be very hard to see other women breast-
feed. But there was one nurse* who came in and 
asked “Why don’t you like to breastfeed?”. And I had 
to explain what HTLV was. Ah, not being allowed 
to breastfeed was hard, right? (gets emotional) And 
when she (the daughter) cried, my breast filled. Then 
my breasts were bandaged so as not to have contact 
with her. But who really suffered was her father. But it 
was difficult that everyone was asking “oh dear, she’s so 
big, does she drink a lot?” Everyone asking, my neigh-
bors. Not in my house, because I told them (about the 
HTLV) (Maria, 27 years, married, asymptomatic).
In the hospital context, different actors partici-
pate, who may or may not serve as facilitators of the 
inhibition process of breastfeeding. A first actor is 
the health team and, although the majority showed 
to be prepared to cope with the situation, one team 
member was surprised at the situation and inquired 
about the reasons not to breastfeed. The profession-
al mentioned not only demonstrates a critical pos-
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ture towards the inhibition process of breastfeeding, 
but also illustrates a total lack of knowledge on the 
patient’s specific medical situation. It is highlighted 
that, although the interviewees refer to nursing pro-
fessionals, it was not clarified whether the nursing 
professional mentioned was the nurse or another 
member of the nursing team (see footnote).
Maria’s discourse also reveals the role of the oth-
er patients’ looks, as Maria mentioned difficulty to 
see (another woman breastfeeding) and to be seen 
(inhibiting the breastfeeding), putting the inhibit-
ing of breastfeeding in the position of core signifier 
in the expression of her condition as a WLHTLV.
As for the companions and relatives, the experi-
ences are similar to those reported by women living 
with HIV/Aids,(19) that is, what is observed in the 
anticipation of the situation through information 
for key figures in the family, preparing them for 
moments of commotion and suffering. Concerning 
the visitors - another actor in the hospital scenar-
io - a list of apologies is constructed to justify the 
breastfeeding inhibition. This conduct is intended 
to avoid evidencing the infection by HTLV-1, in 
view of the fear of prejudice and stigmatization. In 
that context, the importance is observed of preg-
nant women’s taking an active stance towards the 
generalized ignorance about HTLV-1. The situa-
tions reported reveal that the hospital setting can 
be a risky environment, that is, women in this con-
dition experience invisibility for the health area, as 
reported by Zihlmann.(16)
Other participants reported on situations in 
which the health teams ignored the HTLV-1 and 
took an inappropriate stance. Maria Rita’s report is 
dramatic and revealed the health team’s pressures 
for her to breastfeed, even after having explained 
that she was seropositive to HTLV-1. This inter-
viewee told that she had been diagnosed (in the 
eighth month of pregnancy) with HTLV-1 and that 
the infectious disease specialist at the specialized re-
ferral center had instructed her not to breastfeed, 
providing a formal statement for that diagnosis. In 
her report, Maria Rita revealed that the conversa-
tion with the health team of the maternity hospital 
was tense and that she was confronted with disbelief 
in her information:
The nurse* brought her (the child) to breastfeed, 
then I said “I won’t breastfeed!” The nurse* said 
“why won’t you breastfeed? You’ve got milk”. I said 
“I’ve got milk, but I can’t breastfeed, I was instructed 
by the infectious disease specialist”. The obstetrician 
said “Yes you can breastfeed!”. The nurse* said “you 
can breastfeed, I’ve talked to the physician and there’s 
no problem”. I said “No! I see a specialist and he ad-
vised me not to breastfeed, because when I got here, 
at this hospital, nobody knew about the topic HTLV, 
why would I trust you now?” (Maria Rita, 27 years, 
asymptomatic).
It should be reminded that Maria Rita had 
her daughter in 2007, in the city of São Pau-
lo, which is considered the region with the best 
access to health in the country.(26) This report 
does not only illustrate a situation of the team’s 
lack of preparation to deliver care to WLHTLV, 
but also reveals the risk this unpreparedness can 
entail. This means that there exists a risk when 
the hospital ignores these subjects’ specific needs 
and does not acknowledge them as subjects with 
rights. It should be highlighted that the final 
consequence is the perpetuation of this infection 
in our midst.(3,7)
Maria Rita also reported that her rights were in-
fringed as, even without any infectious-contagious 
condition, the patient would still have the right to 
decide whether she wants to breastfeed or not. The 
following expert discusses these aspects:
I explained it to the nurse*, but she nevertheless in-
sisted. She put the baby here at my breast. I said I won’t 
breastfeed! She said “I’ll teach you how to breastfeed”. 
Then I took the baby off my breast. Do you think I 
didn’t want to breastfeed? Why did this have to be like 
that? (Maria Rita, 27 years, asymptomatic).
*Foot note: In the interviewees’ statements, the term “nurse” is fre-
quently observed to designate an interlocutor during the hospitaliza-
tion. It is not clear or impossible to distinguish, however, based on the 
statements, whether that person is truly a nursing professional or the 
particularity of her function. For the sake of analysis, we consider that 
the interviewee’s discourse indicated that, from her perspective, that 
person was a nursing professional, independently of other attributes. 
Even if the interlocutor does not come from the nursing area, she was 
identified as such by the interviewee and held responsible for this care 
during the hospitalization. This identification may indicate that the in-
terviewee revealed her viewpoint on the importance and central role of 
this professional’s engagement in the context appointed in this study. 
Therefore, for the sake of this article, the use of the term “nurse” will 
follow the considerations proposed.
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This patient’s posture was firm, as she felt safe as 
a result of the information and support received at 
the specialized center. The continuation of her re-
port shows that she had to ask the infectious disease 
specialist’s help as the health team did not consider 
anything she said was valid.
I said “is there milk here for my daughter? If not, 
someone should bring it”. Then they said “you can’t 
bring other milk! It’s the first breast milk she needs”. I 
had to call the infectious disease specialist on my mo-
bile phone. Dr. J. managed to calm me down and then 
I passed my phone to the hospital pediatrician, who 
was waiting at my side. Afterwards, the pediatrician 
said “it’s best not to breastfeed” (Maria Rita, 27 years, 
asymptomatic).
Finally, this case revealed that the patient bond-
ed with the team at the specialized center, and was 
not merely “informed/advised”. We can infer that 
this bond strengthened her to cope with an incon-
ceivable situation, all the more when we consider 
the sensitiveness of her circumstances.(16)
As a study limitation, we observed that the in-
terviewees’ discourse frequently contains the term 
“nurse” to designate an interlocutor during the 
hospitalization. It is not clear or impossible to dis-
tinguish, however, based on the discourse, whether 
that person is truly a nursing professional or even 
the particularity of her function. Therefore, this 
identification may indicate the central role of this 
professional’s engagement in the context appointed 
in this study.
Conclusion
The interruption of breastfeeding as a way to pre-
vent the vertical transmission of infectious-con-
tagious diseases is a complex decision. Among 
WLHTLV, however, this experience comes with 
additional particularities and anguish, especially 
due to the aggravating factor of the general igno-
rance on this infection. The reports presented re-
veal a gap in health professionals’ education, that 
is, our study unveiled the need for public policies 
that enhance the visibility of HTLV. Preparing the 
pregnant or parturient woman in advance is con-
sidered fundamental in order to help her to play a 
protagonist role, especially in a context of neglect 
of her specific needs. Therefore, diagnosing the in-
fection by HTLV-1 in prenatal care is fundamental 
to guarantee the appropriate conduct of the vertical 
transmission prevention process. This research can 
contribute to dissemination on the subject, besides 
allowing reflection on the need for the construction 
of integral health care, which, after all, can allow the 
welcoming of PVHTLV’s complex needs.
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